Skip to main content
Clinical Trials/JPRN-UMIN000051558
JPRN-UMIN000051558
Not yet recruiting
未知

Optimal analgesia with remifentanil for patients requiring postoperative intensive care. - I-pooR

Hiroshima University0 sites20 target enrollmentJuly 20, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Admission to the Surgical Intensive Care Unit (SICU) after surgery under general anesthesia.
Sponsor
Hiroshima University
Enrollment
20
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 20, 2023
End Date
March 31, 2027
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • A) Cases with atrial fibrillation. B) Cases in which it is inappropriate to perform the observation arterial manometry in the radial artery. C) Patients with significant hemodynamic or neurologic impairment in the upper extremities. D) Patients with severe stenosis or occlusive lesions in cerebral vessels. E) Cases with contraindications to remifentanil, propofol, or rocuronium. F) Patients who are regularly using opioids. G) Cases in which prior consent has been withdrawn. H) Cases in which the anesthesiologist deems the patient unfit to perform this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials